Working Towards Global Patient Access: Emerging Markets in Cell and Gene Therapy
Saturday, June 1, 2024 10:15 AM - 11:15 AM
Room 208-209
Global CGT Markets
Roundtable
Moderator
Understand how CAR Ts are being implemented in emerging markets and debate whether novel therapeutic approaches such as allogeneic NK cells, in vivo gene editing, and combination therapies will enable broader patient access globally.
Key Learning Objectives
Implementing CAR-T Therapy in Developing Countries:
1. Gain insight into the unique challenges faced by developing countries in implementing CAR-T therapy, including limited infrastructure, high costs, and lack of trained personnel.
2. Explore the potential opportunities for enhancing accessibility to CAR-T therapy in developing countries, such as collaboration between stakeholders, technological innovations, and simplified manufacturing processes.
- Desiree Kosan, MS, RN, OCN, Johnson & Johnson Innovative Medicine, United States
- Camila Donadel, MD, Blood Center of Ribeirao Preto, Brazil
- Flávia Mesquita Gava, MD, Blood Center of Ribeirao Preto, Brazil
- Maroun Khoury, PhD, IMPACT - Center of Interventional Medicine for Precision and Advanced Cellular Therapy, Chile
Understand how CAR Ts are being implemented in emerging markets and debate whether novel therapeutic approaches such as allogeneic NK cells, in vivo gene editing, and combination therapies will enable broader patient access globally.
Key Learning Objectives
Implementing CAR-T Therapy in Developing Countries:
1. Gain insight into the unique challenges faced by developing countries in implementing CAR-T therapy, including limited infrastructure, high costs, and lack of trained personnel.
2. Explore the potential opportunities for enhancing accessibility to CAR-T therapy in developing countries, such as collaboration between stakeholders, technological innovations, and simplified manufacturing processes.
Desiree Kosan
CAR-T Cell Collections Operations Manager
Johnson & Johnson Innovative Medicine
Moderator
CAR-T Cell Collections Operations Manager
Johnson & Johnson Innovative Medicine
Moderator
Maroun Khoury
Executive Director
IMPACT-Center of interventional medicine for precision and advanced cellular therapy
Panelist
Executive Director
IMPACT-Center of interventional medicine for precision and advanced cellular therapy
Panelist
